ANIDO ARMANDO
Insider CIK 1219866 · SCYX Director · PATH Chief Executive Officer, Director · ZYNE Chairman & Chief Exec. Officer, Director · BOTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS INC | A Award deriv | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 2,875 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2026-06-26 | 2026-06-30 | 2,875 | — | $0 | 11,750 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2025-06-26 | 2025-06-30 | 23,000 | — | $0 | 71,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2024-06-20 | 2024-06-21 | 23,000 | — | $0 | 48,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 190,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 13,297 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 26,595 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 610,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-10-10 | 2023-10-11 | 240,000 | — | $0 | 610,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 566,722 | — | $0 | 370,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-09-13 | 2023-09-14 | 17,830 | $1.33 | $23.7K | 936,722 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-09-12 | 2023-09-14 | 64,747 | — | $0 | 954,552 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2023-06-15 | 2023-06-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2023-06-15 | 2023-06-23 | 10,000 | — | $0 | 25,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-08 | 2023-02-09 | 12,547 | $0.60 | $7.5K | 889,805 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-02-07 | 2023-02-09 | 45,406 | — | $0 | 902,352 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-01 | 2023-02-02 | 11,726 | $0.60 | $7.0K | 856,946 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-31 | 2023-02-02 | 42,437 | — | $0 | 868,672 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-24 | 2023-01-25 | 250,000 | — | $0 | 826,235 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-01-23 | 2023-01-25 | 35,453 | $0.60 | $21.3K | 576,235 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-07-19 | 2022-07-20 | 11,899 | $1.10 | $13.1K | 611,688 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-07-18 | 2022-07-20 | 43,164 | — | $0 | 623,587 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award | 2022-06-17 | 2022-06-22 | 10,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-01-26 | 2022-01-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-01-26 | 2022-01-28 | 120,000 | — | $0 | 580,423 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2021-06-16 | 2021-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-01-21 | 2021-01-25 | 161,867 | — | $0 | 161,867 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-01-21 | 2021-01-25 | 107,911 | — | $0 | 460,423 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-12-21 | 2020-12-23 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2020-12-21 | 2020-12-23 | 5,000 | $6.25 | $31.3K | 5,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2021-03-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2020-07-06 | 2020-07-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 162,480 | — | $0 | 162,480 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-06-18 | 2019-06-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-28 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-30 | 160,000 | — | $0 | 160,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-01-21 | 2019-01-23 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-08-06 | 2018-08-07 | 15,000 | $5.96 | $89.4K | 352,512 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-11 | 2018-01-16 | 81,000 | — | $0 | 81,000 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2017-05-18 | 2017-05-22 | 20,000 | $0.49 | $9.8K | 75,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-05-15 | 2017-05-16 | 1,500 | $19.57 | $29.4K | 337,512 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2017-05-12 | 2017-05-16 | 3,500 | $19.76 | $69.2K | 336,012 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AVIR Aviragen Therapeutics, Inc | A Award deriv | 2016-05-12 | 2016-05-13 | 20,000 | $1.50 | $30.0K | 20,000 | SEC↗ |
| BOTA Biota Pharmaceuticals, Inc | A Award deriv | 2015-09-21 | 2015-10-21 | 35,000 | $1.95 | $68.3K | 35,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion deriv | 2015-08-10 | 2015-08-10 | 50,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion deriv | 2015-08-10 | 2015-08-10 | 25,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion | 2015-08-10 | 2015-08-10 | 13,297 | — | $0 | 13,297 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | C Conversion | 2015-08-10 | 2015-08-10 | 26,595 | — | $0 | 26,595 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2015-08-04 | 2015-08-06 | 396,678 | — | $0 | 396,678 | SEC↗ |
| PATH NUPATHE INC. | D To issuer | 2014-02-21 | 2014-02-25 | 1,270,000 | $6.80 | $8.64M | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-17 | 2013-01-22 | 317,580 | — | $0 | 1,270,000 | SEC↗ |
| PATH NUPATHE INC. | D To issuer deriv | 2013-01-07 | 2013-01-09 | 738,190 | — | $0 | 0 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2013-01-07 | 2013-01-09 | 369,095 | — | $0 | 952,420 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2012-12-31 | 2013-01-03 | 116,665 | — | $0 | 116,665 | SEC↗ |
| PATH NUPATHE INC. | A Award | 2012-12-31 | 2013-01-03 | 466,660 | — | $0 | 466,660 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-07-25 | 2012-07-27 | 738,190 | — | $0 | 738,190 | SEC↗ |